← Leaderboards
Eric T. Harvill
Pennsylvania State University-Univ Park
$9,581,699
Attributed
$10,152,979
Total exposure
17
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $916.7K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,122,979 · 16
FDA$30,000 · 1
By mechanism
R01$5,904,562 · 4
R21$3,105,074 · 8
R56$1,108,343 · 3
R13$35,000 · 2
Top collaborators
- Jennifer A Maynard3 shared
Others in their field
Top investigators on “Infection”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,939,185
- Lawrence Corey · Fred Hutchinson Cancer Center$789,608,171
- Judith S. Currier · University Of California Los Angeles$511,038,212
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$463,711,983
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$415,229,497
Research focus
InfectionPertussisPathogenVirulence FactorsBordetellaRespiratory SystemMouse ModelAnimalsMediatingImmuneBaseBacteriaTransmission ProcessRespiratoryComplexGenesVaccinesAffectBordetella Pertussis BacteriumGeneticImmunityPreventPertussis VaccineExperimental Study
Grant awards (39)
Maternal vaccination impacts on neonatal susceptibility and response to Bordetella pertussis$212,265
R21 · FY2025 · AI · contact PI
An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia$188,750
R21 · FY2024 · AI · contact PI
An air-liquid interface system to study Bordetella pertussis interactions with respiratory epithelia$220,890
R21 · FY2023 · AI · contact PI
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis$188,750
R21 · FY2022 · AI · contact PI
Protection against Bordetella pertussis transmission conferred by established and novel vaccines$188,750
R21 · FY2022 · AI · contact PI
Are acellular vaccines driving the rise of pertactin-deficient Bordetella pertussis$226,500
R21 · FY2021 · AI · contact PI
Protection against Bordetella pertussis transmission conferred by established and novel vaccines$226,500
R21 · FY2021 · AI · contact PI
Bacterial factors and host response in chronic otitis media$188,750
R21 · FY2021 · DC · contact PI
Vaccine targeting catarrhal stage of pertussis disease$369,093
R56 · FY2020 · AI · contact PI
Bacterial factors and host response in chronic otitis media$226,500
R21 · FY2020 · DC · contact PI
An optimized mouse model of Bordetella pertussis infection$188,750
R21 · FY2020 · AI · contact PI
An optimized mouse model of Bordetella pertussis infection$225,500
R21 · FY2019 · AI · contact PI
A Novel Polysaccharide Structure that Mediates Transmission$225,000
R21 · FY2019 · AI · contact PI
12th International Bordetella Symposium$30,000
R13 · FY2019 · FD · contact PI
12th International Symposium on Bordetella$5,000
R13 · FY2019 · AI · contact PI
Systematic evaluation of B. pertussis ACTâs role as a protective antigen$375,718
R01 · FY2018 · AI
The Microbiota Pathogen Competition$353,433
R01 · FY2018 · GM · contact PI
A Novel Polysaccharide Structure that Mediates Transmission$187,500
R21 · FY2018 · AI · contact PI
Systematic evaluation of B. pertussis ACTâs role as a protective antigen$376,277
R01 · FY2017 · AI
The Microbiota Pathogen Competition$288,750
R01 · FY2017 · GM · contact PI
The Microbiota Pathogen Competition$64,683
R01 · FY2017 · GM · contact PI
Systematic evaluation of B. pertussis ACTâs role as a protective antigen$390,565
R01 · FY2016 · AI
The Microbiota Pathogen Competition$288,750
R01 · FY2016 · GM · contact PI
In vivo vaccine-driven evolution in Bordetella pertussis$222,294
R21 · FY2016 · AI · contact PI
The Microbiota Pathogen Competition$290,098
R01 · FY2015 · GM · contact PI
In vivo vaccine-driven evolution in Bordetella pertussis$188,375
R21 · FY2015 · AI · contact PI
Bordetella sp. Versus Microbiota$376,750
R56 · FY2014 · AI · contact PI
Evolution of the Bordetellae from Commensals to Pathogens$435,824
R01 · FY2011 · GM · contact PI
Evolution of the Bordetellae from Commensals to Pathogens$442,956
R01 · FY2010 · GM · contact PI
Evolution of the Bordetellae from Commensals to Pathogens$436,579
R01 · FY2009 · GM · contact PI
Evolution of the Bordetellae from Commensals to Pathogens$384,822
R01 · FY2009 · GM · contact PI
Evolution of the Bordetellae from Commensals to Pathogens$418,673
R01 · FY2008 · GM · contact PI
EMERGENCE OF HUMAN PATHOGENS IN THE GENUS BORDETELLA$362,500
R56 · FY2007 · AI · contact PI
Comparative Immunobiology of the bordetellae$315,249
R01 · FY2007 · AI · contact PI
Comparative Immunobiology of the bordetellae$299,669
R01 · FY2006 · AI · contact PI
Comparative Immunobiology of the bordetellae$29,089
R01 · FY2006 · AI · contact PI
Comparative Immunobiology of the bordetellae$308,437
R01 · FY2005 · AI
Comparative Immunobiology of the bordetellae$309,852
R01 · FY2004 · AI
Comparative Immunobiology of the bordetellae$95,138
R01 · FY2003 · AI